2-240869004-G-C

Variant summary

Our verdict is Pathogenic. The variant received 27 ACMG points: 27P and 0B. PS1_Very_StrongPM1PM2PM5PP2PP3_StrongPP5_Very_Strong

The NM_000030.3(AGXT):​c.139G>C​(p.Gly47Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000000736 in 1,358,806 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Pathogenic in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G47E) has been classified as Likely pathogenic.

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 7.4e-7 ( 0 hom. )

Consequence

AGXT
NM_000030.3 missense

Scores

9
6
3

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:2

Conservation

PhyloP100: 5.63

Publications

11 publications found
Variant links:
Genes affected
AGXT (HGNC:341): (alanine--glyoxylate aminotransferase) This gene is expressed only in the liver and the encoded protein is localized mostly in the peroxisomes, where it is involved in glyoxylate detoxification. Mutations in this gene, some of which alter subcellular targetting, have been associated with type I primary hyperoxaluria. [provided by RefSeq, Jul 2008]
AGXT Gene-Disease associations (from GenCC):
  • alanine glyoxylate aminotransferase deficiency
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • primary hyperoxaluria type 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Myriad Women’s Health, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 27 ACMG points.

PS1
Transcript NM_000030.3 (AGXT) is affected with MISSENSE_VARIANT having same AA change as one Pathogenic present in ClinVar.
PM1
In a hotspot region, there are 5 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 2 benign, 4 uncertain in NM_000030.3
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr2-240869005-G-A is described in ClinVar as Likely_pathogenic. ClinVar VariationId is 2681153.Status of the report is criteria_provided_single_submitter, 1 stars.
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 130 curated pathogenic missense variants (we use a threshold of 10). The gene has 12 curated benign missense variants. Gene score misZ: -0.26789 (below the threshold of 3.09). Trascript score misZ: -0.48778 (below the threshold of 3.09). GenCC associations: The gene is linked to alanine glyoxylate aminotransferase deficiency, primary hyperoxaluria type 1.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.995
PP5
Variant 2-240869004-G-C is Pathogenic according to our data. Variant chr2-240869004-G-C is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 2681194.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGXTNM_000030.3 linkc.139G>C p.Gly47Arg missense_variant Exon 1 of 11 ENST00000307503.4 NP_000021.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGXTENST00000307503.4 linkc.139G>C p.Gly47Arg missense_variant Exon 1 of 11 1 NM_000030.3 ENSP00000302620.3

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD2 exomes
AF:
0.00000411
AC:
1
AN:
243256
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
7.36e-7
AC:
1
AN:
1358806
Hom.:
0
Cov.:
34
AF XY:
0.00
AC XY:
0
AN XY:
674372
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30812
American (AMR)
AF:
0.00
AC:
0
AN:
41702
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23032
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35774
South Asian (SAS)
AF:
0.00
AC:
0
AN:
80498
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
42948
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5314
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1044294
Other (OTH)
AF:
0.0000184
AC:
1
AN:
54432
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
31
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:1
Feb 02, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 47 of the AGXT protein (p.Gly47Arg). This variant is present in population databases (rs180177173, gnomAD 0.003%). This missense change has been observed in individual(s) with primary hyperoxaluria type 1 (PMID: 17460142, 20564000). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt AGXT protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects AGXT function (PMID: 24718375, 26149463). For these reasons, this variant has been classified as Pathogenic.

Primary hyperoxaluria, type I Pathogenic:1
Oct 27, 2023
Clinical Biochemistry Laboratory, Health Services Laboratory
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:curation

ACMG:PS1 PM2 PP3

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.56
BayesDel_addAF
Pathogenic
0.41
D
BayesDel_noAF
Pathogenic
0.45
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.96
D
Eigen
Uncertain
0.34
Eigen_PC
Benign
0.083
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Benign
0.71
T
M_CAP
Pathogenic
0.76
D
MetaRNN
Pathogenic
1.0
D
MetaSVM
Pathogenic
0.84
D
MutationAssessor
Pathogenic
4.2
H
PhyloP100
5.6
PrimateAI
Benign
0.47
T
PROVEAN
Pathogenic
-7.1
D
REVEL
Pathogenic
0.67
Sift
Uncertain
0.0010
D
Sift4G
Uncertain
0.0040
D
Vest4
0.77
ClinPred
0.99
D
GERP RS
2.6
PromoterAI
-0.0038
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.93
gMVP
0.95
Mutation Taster
=35/65
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs180177173; hg19: chr2-241808421; API